Cardamom, a plant of Indian origin, may help you fight triple-negative breast cancer cells, says a new American study. This discovery could enable scientists to find new ways to fight this type of cancer, which could develop resistance to common treatments. Cardamom has many natural properties, including therapeutic properties. The plant could help fight triple-negative breast cancer cells, according to researchers at the Florida Agricultural and Mechanical University. Its effectiveness is due to cardamom, a natural ingredient present in spices.Also read – Ayurveda Tips: 5 Healthy Reasons Why You Should Add Cardamom to Your Diet Immediately
Triple-negative breast cancer is an important health problem because it is difficult to treat. The Institute Curie Research Center explains that they develop on the surface of cancer cells without any known markers that would respond to known targeted therapies. Also read – Drinking wine with meals may reduce the risk of developing type 2 diabetes: a study
To do his research, Dr. Patricia Mendonca and colleagues studied the effects of cardamonin on two triple-negative breast cancer cell lines – one made up of African American women’s cells and the other made up of Caucasian women’s cells. Also read – Do you know about the ABC of breast cancer self-examination?
According to an American study, cardamom, a plant of Indian origin, may help fight triple-negative breast cancer.
According to an American study, cardamom, a plant of Indian origin, can fight against triple negative breast cancer cells. This discovery could enable scientists to find new ways to fight this type of cancer, which could develop resistance to common treatments.
Cardamom has many natural properties, including therapeutic properties. According to researchers at Florida Agricultural and Mechanical University, the plant could help fight triple-negative breast cancer cells. Its effectiveness is due to cardamom, a natural ingredient present in spices.
Triple-negative breast cancer is an important health problem because it is difficult to treat. The Institute Curie Research Center explains that they develop on the surface of cancer cells without any known markers that would respond to known targeted therapies.
To do his research, Dr. Patricia Mendonca and colleagues studied the effects of cardamonin on two triple-negative breast cancer cell lines – one made up of African American women’s cells and the other made up of Caucasian women’s cells.
The researchers observed how cardamom ligand-1 (PD-L1) affects gene expression, which is responsible for programmed cell death. In patients with triple-negative breast cancer, PD-L1 is over-expressed, “and plays an important role in helping breast cancer cells fight off the body’s immune system,” the study explains.
Researchers have found that cardamom treatment can reduce the efficiency of cancer cells in both African-American and Caucasian patients. Furthermore, it reduces PD-L1 expression in the Caucasian cell line but not in the African American cell line.
“This is the first study to describe the inhibitory effect of cardemonin on the expression of PD-L1, which is related to the treatment of triple-negative breast cancer,” Mendonca said. “These findings support other research that has shown differences in tumor microenvironments between African and non-African Americans.” Further research is needed before the treatment can be tested on humans.
(AFP)
